Open AccessInterleukin-6, C-reactive protein, fibrinogen, and risk of recurrence after ischaemic stroke: Systematic review and meta-analysis
Author(s) -
John McCabe,
Éilis J. O’Reilly,
Sarah Coveney,
Rory Collins,
L Healy,
John McManus,
Ríona Mulcahy,
Barry Moynihan,
Tim Cassidy,
FangChi Hsu,
Brad Worrall,
Seán Murphy,
Martin O’Donnell,
Peter Kelly
Publication year - 2021
Publication title -
european stroke journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 16
eISSN - 2396-9881
pISSN - 2396-9873
DOI - 10.1177/2396987320984003
Subject(s) - medicine , fibrinogen , meta analysis , stroke (engine) , hazard ratio , c reactive protein , gastroenterology , surgery , confidence interval , inflammation , mechanical engineering , engineering
Recent randomised trials showed benefit for anti-inflammatory therapies in coronary disease but excluded stroke. The prognostic value of blood inflammatory markers after stroke is uncertain and guidelines do not recommend their routine measurement for risk stratification.